These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 24280125)
1. Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling. Garulli C; Kalogris C; Pietrella L; Bartolacci C; Andreani C; Falconi M; Marchini C; Amici A Cell Signal; 2014 Feb; 26(2):352-62. PubMed ID: 24280125 [TBL] [Abstract][Full Text] [Related]
2. ΔNp63α-mediated activation of bone morphogenetic protein signaling governs stem cell activity and plasticity in normal and malignant mammary epithelial cells. Balboni AL; Hutchinson JA; DeCastro AJ; Cherukuri P; Liby K; Sporn MB; Schwartz GN; Wells WA; Sempere LF; Yu PB; DiRenzo J Cancer Res; 2013 Jan; 73(2):1020-30. PubMed ID: 23243027 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer. Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152 [TBL] [Abstract][Full Text] [Related]
4. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition. Bosukonda A; Carlson WD Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676 [TBL] [Abstract][Full Text] [Related]
5. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis. Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892 [TBL] [Abstract][Full Text] [Related]
6. p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells. Bisaro B; Montani M; Konstantinidou G; Marchini C; Pietrella L; Iezzi M; Galiè M; Orso F; Camporeale A; Colombo SM; Di Stefano P; Tornillo G; Camacho-Leal MP; Turco E; Taverna D; Cabodi S; Amici A; Defilippi P Breast Cancer Res; 2012 Oct; 14(5):R137. PubMed ID: 23098208 [TBL] [Abstract][Full Text] [Related]
7. Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin. Langenfeld E; Deen M; Zachariah E; Langenfeld J Mol Cancer; 2013 Oct; 12(1):129. PubMed ID: 24160469 [TBL] [Abstract][Full Text] [Related]
8. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition. Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100 [TBL] [Abstract][Full Text] [Related]
9. BMP-4 enhances epithelial mesenchymal transition and cancer stem cell properties of breast cancer cells via Notch signaling. Choi S; Yu J; Park A; Dubon MJ; Do J; Kim Y; Nam D; Noh J; Park KS Sci Rep; 2019 Aug; 9(1):11724. PubMed ID: 31409851 [TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins. Chen D; Zhao M; Mundy GR Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726 [TBL] [Abstract][Full Text] [Related]
11. The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation. Buijs JT; van der Horst G; van den Hoogen C; Cheung H; de Rooij B; Kroon J; Petersen M; van Overveld PG; Pelger RC; van der Pluijm G Oncogene; 2012 Apr; 31(17):2164-74. PubMed ID: 21996751 [TBL] [Abstract][Full Text] [Related]
12. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer. Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352 [TBL] [Abstract][Full Text] [Related]
13. BMP signaling and its paradoxical effects in tumorigenesis and dissemination. Zhang L; Ye Y; Long X; Xiao P; Ren X; Yu J Oncotarget; 2016 Nov; 7(47):78206-78218. PubMed ID: 27661009 [TBL] [Abstract][Full Text] [Related]
14. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272 [TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression. Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy. Jin X; Jin X; Kim LJY; Dixit D; Jeon HY; Kim EJ; Kim JK; Lee SY; Yin J; Rich JN; Kim H Clin Cancer Res; 2018 Jan; 24(2):383-394. PubMed ID: 29208670 [No Abstract] [Full Text] [Related]
17. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer. Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155 [TBL] [Abstract][Full Text] [Related]
19. Long-term exposure to bisphenol A or benzo(a)pyrene alters the fate of human mammary epithelial stem cells in response to BMP2 and BMP4, by pre-activating BMP signaling. Clément F; Xu X; Donini CF; Clément A; Omarjee S; Delay E; Treilleux I; Fervers B; Le Romancer M; Cohen PA; Maguer-Satta V Cell Death Differ; 2017 Jan; 24(1):155-166. PubMed ID: 27740625 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of inhibition of bone morphogenic protein (BMP) signalling on T-cell activation and differentiation. Yoshioka Y; Ono M; Osaki M; Konishi I; Sakaguchi S Eur J Immunol; 2012 Mar; 42(3):749-59. PubMed ID: 22144105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]